What a difference a couple years can make. I was reviewing my 2020 presentation to the members of MHCA (formerly the Mental Health Corporations of America) at their 35th anniversary gathering, and I was struck by what was missing from my timeline of the science of mental health treatment—the many new advances in digital treatment interventions (see The Future Has Already Happened).

Just this September, the U.S. Food and Drug Administration (FDA) approved the first-ever twice-yearly injectable antipsychotic (see Janssen Announces U.S. FDA Approval of Invega Hafyera). And we recently saw the approval of a . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!